Business Wire

Open letter to Europe by André Rogaczewski CEO and co-founder of Netcompany: Europe must stand tall

23.4.2025 06:30:00 CEST | Business Wire | Press release

Share

On the night of 22 April, the Statue of Liberty at Pont de Grenelle in Paris was illuminated with the message: “Stand Tall Europe”. Once a gift symbolising the transatlantic alliance and shared ideals of the West, the statue now stands as a reminder of a fellowship through centuries that is put under heavy pressure.

The following is an open letter by André Rogaczewski CEO and co-founder of Netcompany:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422921783/en/

Statue of Liberty at Pont de Grenelle last night in Paris – Iluminated with the message ”Stand Tall Europe”.

Europeans,

This is your digital awakening.

We all know that leading technologically is paramount for competitiveness and the creation of growth, prosperity, and welfare.

Europe’s digital backbone is to a large extent built on systems we don’t necessarily control. From data centers to cloud systems – in the applications and algorithms that shape our decisions.

While we rely on digital services in all our core societal areas— communication, financial services, welfare benefits, pensions, healthcare, even elections—the digital applications and infrastructures behind are too often dependent on non-European systems.

What we need is a response. To protect our individual rights, and shape a digital European ecosystem rooted in our own democratic values – not those imposed by people who no longer necessarily share our beliefs.

That’s why Netcompany launched a campaign on the night of 22 April by illuminating the Statue of Liberty in Paris with the message: “Stand Tall Europe”.

We chose the Statue of Liberty because it stands as a symbol of freedom, justice, the end of oppression, and opportunity for all. A gift from Europe to the US symbolising the values we created together and used to share. It seems now that Europe herself alone is facing the challenge of protecting those same ideals in a digital world.

Where the Statue of Liberty lifts a torch, Europe’s task today is to light the digital path forward—by asserting digital sovereignty, defending rights online, and building our own trusted secure systems and applications that our societies can rely on and prosper with.

We must embrace the digital revolution, establish more European datacenters, set up trusted age-verification systems to protect our children, and ensure our voters are not filled with digital propaganda.

We must quickly build trustworthy, robust, fair, and transparent applications and systems showing everyone else that responsible digital transformation is the way to create world-leading innovation, growth and progress.

That means offensively using AI designed with European values and transparency to create efficient European private and public administration. It means developing intelligent digital twins for our physical infrastructure across all industries to uniquely optimise European businesses. In fact, we must build world leading digital applications for Europe to become a leading region of the world.

We are calling for more European solutions—built by European companies, accountable to European citizens.

Europe’s future prosperity and growth depends on it and hence it also depends on our ability to attract, develop, and unite diverse world-class talent from everywhere.

We must make this continent the most attractive destination for the world’s sharpest minds.

This is also a call for all of you who want to contribute to the European digital awakening, wherever you are. We need you.

There’s no quick fix. But we are ready. We believe in a digital future where Europe owns more of its systems, protects its citizens, and leads with integrity.

Let’s take back the future.

Yours sincerely,

André Rogaczewski

CEO and co-founder of Netcompany

About André Rogaczewski

​André Rogaczewski founded Netcompany in 2000 and has overseen its evolution into one of Europe’s fastest growing and most successful IT services companies, with a global headcount of +8,250 talented employees across +10 European countries.

With his technical background, a master's degree in computer science from Aalborg University and a true vision for society’s digital future, he has led the company through tremendous growth and built a unique delivery model unmatched elsewhere in the IT industry. André was born in Poland and grew up in Aalborg, Denmark.

About Netcompany

Founded in 2000 in Copenhagen, Denmark, Netcompany provides essential IT solutions for both societal and business needs, aiding our private and public clients in their digital evolution towards a more efficient and sustainable future.

Our team of skilled professionals drives sustainable innovation, consistently advancing and expanding our impact - one solution at a time.

By building flexible, scalable and secure digital solutions, we help Europe lead the way towards responsible digitalisation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250422921783/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release

Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye